On this page we presented the CNCE historical earnings date information for Concert Pharmaceuticals. Reviewing that CNCE Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q3 2017, when CNCE posted gaap of 5.44/share. Meanwhile the lowest CNCE historical earnings result was in FY 2013, when CNCE posted gaap of -4.99/share. Moving to Concert Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q3 2017 when CNCE reported 143.84M in revenue, while the smallest revenue quarter was Q1 2022 when CNCE reported NA in revenue.

For self directed investors doing their due diligence on CNCE or any other given stock, their research can benefit from looking into all of the Concert Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Concert Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for CNCE. Thanks for visiting, and the next time you need to research CNCE historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.